Amanda Cashen, M.D. - Clinical Trial Investigator | Syfrah

Trials Sponsors Conditions Drugs Pricing

Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(15)

DRUG(8)

PROCEDURE(5)

BIOLOGICAL(2)

phase_1_2phase_2

washington-university-school-of-medicine

Cyclophosphamide

phase_1_2phase_2

washington-university-school-of-medicine

phase_1_2phase_2

washington-university-school-of-medicine

CIML NK cell infusion

phase_1_2phase_2

washington-university-school-of-medicine

Bone marrow for correlative studies

washington-university-school-of-medicine

washington-university-school-of-medicine

washington-university-school-of-medicine

Dynamic contrast-enhanced computed tomography

washington-university-school-of-medicine

+18 more interventions

26 unique interventions5 categories

Analytics

Trial Phases

Phase 13

Phase 26

Trial Status

Completed4

Terminated2

Other2

Role Distribution

Principal Investigator8

PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT04331119Phase 2Terminated

Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas

T-Cell Lymphoma

PrincipalinvestigatorStart date: 2020-07-23

NCT03068819Phase 1/2Completed

Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

Acute Myeloid Leukemia

PrincipalinvestigatorStart date: 2017-10-23

NCT02782546Phase 2Active Not Recruiting

Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

Acute Myeloid Leukemia

PrincipalinvestigatorStart date: 2017-01-30

NCT01898793Phase 1/2Terminated

Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Leukemia, Myeloid, Acute

PrincipalinvestigatorStart date: 2014-08-11

NCT01969435Phase 2Completed

Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma

Hodgkin DiseaseLymphoma, Non-Hodgkin

PrincipalinvestigatorStart date: 2014-03-19

NCT01001143Phase 1Completed

Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)

Leukemia, Myeloid, Acute

Principalinvestigator

NCT02117115Early Phase 1Completed

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Leukemia, Myelogenous, ChronicLeukemia, Myeloid, AcuteMultiple Myeloma+1 more

Principalinvestigator

NCT04893915Phase 2Withdrawn

Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS

Myelodysplastic SyndromesRefractory Acute Myeloid LeukemiaRelapsed Acute Myeloid Leukemia

Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

CO

High-influence Collaborator

CO

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Leukemia, Myeloid, Acute5 Myelodysplastic Syndromes2 Hodgkin Disease1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive1 Lymphoma, Non-Hodgkin1 Multiple Myeloma1 Refractory Acute Myeloid Leukemia1 Relapsed Acute Myeloid Leukemia1

Affiliations

Washington University School of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, Acute+3 more

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score20%

Arnon Nagler, MD

Chaim Sheba Medical Center

Shared therapeutic areas:

Hodgkin DiseaseMultiple MyelomaLymphoma, Non-Hodgkin+3 more

Similarity Score20%

Yves Beguin, MD, PhD

CHU-ULg

Shared therapeutic areas:

Hodgkin DiseaseLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, Acute+3 more

Similarity Score20%

Qifa Liu

Nanfang Hospital, Southern Medical University

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL Positive+1 more

Similarity Score13%

David Avigan, MD

Beth Israel Deaconess Medical Center

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcuteHodgkin Disease+1 more

Worked with same sponsors:

National Cancer Institute (NCI)National Institutes of Health (NIH)

Similarity Score13%

Beata Holkova, MD

Massey Cancer Center

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score10%

Areej El-Jawahri, MD

Massachusetts General Hospital

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMultiple MyelomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)National Institutes of Health (NIH)+1 more

Similarity Score10%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score10%

Courtney DiNardo, MD

M.D. Anderson Cancer Center

Shared therapeutic areas:

Leukemia, Myeloid, AcuteRefractory Acute Myeloid LeukemiaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score10%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Shared therapeutic areas:

Lymphoma, Non-HodgkinMultiple Myeloma

Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT04331119Phase 2PrincipalInvestigator

Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas

T-Cell Lymphoma

Terminated

NCT03068819Phase 1/2PrincipalInvestigator

Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

Acute Myeloid Leukemia

Completed

NCT02782546Phase 2PrincipalInvestigator

Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

Acute Myeloid Leukemia

Active Not Recruiting

NCT01898793Phase 1/2PrincipalInvestigator

Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Leukemia, Myeloid, Acute

Terminated

NCT01969435Phase 2PrincipalInvestigator

Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma

Hodgkin DiseaseLymphoma, Non-Hodgkin

Completed

NCT01001143Phase 1PrincipalInvestigator

Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)

Leukemia, Myeloid, Acute

Completed

NCT02117115Early Phase 1PrincipalInvestigator

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Leukemia, Myelogenous, ChronicLeukemia, Myeloid, AcuteMultiple Myeloma+1 more

Completed

NCT04893915Phase 2PrincipalInvestigator

Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS

Myelodysplastic SyndromesRefractory Acute Myeloid LeukemiaRelapsed Acute Myeloid Leukemia

Withdrawn

All 8 trials loaded